Navigation Links
New Light on Jane Austen's Final Chapter
Date:12/2/2009

Novelist's symptoms point to death from TB, not Addison's, researcher says

WEDNESDAY, Dec. 2 (HealthDay News) -- The woman behind Pride and Prejudice and Emma may have died of tuberculosis rather than Addison's disease, as has long been believed, says one British scholar.

Since Jane Austen's death in 1817 at the age of 41, many historians and other experts have believed the cause was Addison's disease, which affects the adrenal glands and creates problems with blood pressure and heart function. The disease was always fatal until effective treatment became available in the 1950s.

But Katherine White, a member of the Addison's Disease Self-Help Group, analyzed Austen's letters in the two years before she died and concluded that the symptoms described by the writer suggest Addison's wasn't the culprit.

Austen said she experienced exhaustion, rheumatic pains, unusual skin discoloration and bilious attacks -- all of which could be symptoms of Addison's disease. However, she makes no mention of other symptoms -- generalized pain, weight loss, mental confusion and loss of appetite -- experienced by most people with the disease.

White noted that disseminated tuberculosis, affecting the joints and liver, "would have been more common in Jane Austen's time and would offer a simpler explanation for her symptoms."

Some medical historians have suggested that Austen could have acquired disseminated tuberculosis infection from cows or by drinking unpasteurized milk.

In 1964, physician and surgeon Zachary Cope suggested that Austen may have died from tubercular Addison's disease.

"...It is likely that Cope's hypothesis of infective tuberculosis as the source of her illness was at least partially correct, after all," White wrote.

The article was published online Nov. 30 in the journal Medical Humanities.

More information

The American Lung Association has more about tuberculosis .



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, Nov. 30, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Study shines more light on benefit of vitamin D in fighting cancer
3. Bacteria See the Light
4. Quantum light beams good for fast technology
5. Free will takes flight: how our brains respond to an approaching menace
6. New MRI finding sheds light on multiple sclerosis disease progressio
7. RA Drugs Linked to Slight Skin Cancer Risk
8. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
9. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
10. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
11. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 , ... ... decreases in medical payments per workers’ compensation claim in 2013 and 2014, according to ... Workers Compensation Research Institute (WCRI) . , According to the study, medical payments per ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance Agency, ... Hamilton County, is embarking on a charity drive with the aim of generating ... for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts volunteers ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a locally owned ... clients in the northern Alabama and Georgia regions, is embarking on a charity ... Works has built a network of support and education facilities to develop and ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... Atlanta, Georgia (PRWEB) , ... ... ... announced today it has acquired Presence Technology, S.L. (“Presence”) for a purchase ... certain price adjustments and other considerations. Presence’s annual revenue is approximately $13.2 ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch die CFDA sowie ... – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress ... Union Hospital ...
(Date:12/8/2016)... , Dec. 8, 2016  Boehringer Ingelheim announced today ... Equality Index (CEI). This is the ninth time that ... designated as a Best Place to Work for LGBT ... CEI is a national benchmarking report on corporate policies ... bisexual and transgender (LGBT) employees. "We ...
Breaking Medicine Technology: